𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antibodies to native and denatured collagens in sera of patients with rheumatoid arthritis

✍ Scribed by Nicolaos A. Andriopoulos; Jiri Mestecky; Edward J. Miller; Edwin L. Bradley

Publisher
John Wiley and Sons
Year
1976
Tongue
English
Weight
470 KB
Volume
19
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

A passive hemagglutination assay was used to detect antibodies to native human collagens and to collagen chains in the sera of 110 rheumatoid patients and those of 75 normal controls. The incidence and titer of anticollagen antibodies in rheumatoid arthritis are high, but in controls they are low or in most instances absent. No correlation was found between the stage of RA, or titers of rheumatoid factor, or ANA and the incidence and/or titers of antibody to any given type of collagen.

πŸ“œ SIMILAR VOLUMES

Development of antiinfliximab antibodies
Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis
✍ Gerrit Jan Wolbink; Marijn Vis; Willem Lems; Alexandre E. Voskuyl; Els De Groot; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 80 KB πŸ‘ 1 views

## Abstract ## Objective Treatment of patients with infliximab, a chimeric monoclonal IgG1 antibody against tumor necrosis factor, may result in the formation of infliximab‐specific IgG antibodies. This study evaluated the clinical significance of these antibodies in patients with rheumatoid arthr

Reactivity of serum antibodies to the ke
Reactivity of serum antibodies to the keratin layer of rat esophagus in patients with rheumatoid arthritis
✍ Francisco P. Quismorio Jr; Ronald L. Kaufman; Thomas Beardmore; Edward S. Mongan πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 486 KB πŸ‘ 1 views

## Abstract Serum antibodies reactive with the keratin layer of rat esophagus (AKA) were found in 46 of 80 (57.5%) rheumatoid arthritis (RA) patients. In contrast, AKA were present in only 7 of 82 (9.5%) patients with other types of rheumatic disorders and in 2 of 47 (4.2%) healthy subjects. AKA we